Cambium Bio Limited (ASX:CMB)
Australia · Delayed Price · Currency is AUD 0.4800
0.00 (0.00%)
At close: Mar 26, 2026
Cambium Bio Market Cap
Cambium Bio has a market cap or net worth of 13.12 million as of March 27, 2026. Its market cap has increased by 181.95% in one year.
Market Cap
13.12M
Enterprise Value
n/a
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
0.48
Market Cap Chart
Since April 5, 2024, Cambium Bio's market cap has increased from 7.97M to 13.12M, an increase of 64.66%. That is a compound annual growth rate of 28.77%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 26, 2026 | 13.12M | 21.53% |
| Dec 31, 2025 | 10.80M | 103.21% |
| Dec 31, 2024 | 5.31M | -33.33% |
| Apr 5, 2024 | 7.97M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Argenica Therapeutics | 23.12M |
| Noxopharm | 17.82M |
| Neurotech International | 16.85M |
| Patrys | 16.06M |
| Immuron | 10.78M |
| Bio-Gene Technology | 10.68M |
| AdAlta | 10.20M |
| Tissue Repair | 9.67M |